<!doctype html>
<!--[if lt IE 7]><html class="no-js no-svg ie ie6 lt-ie9 lt-ie8 lt-ie7" lang="en-US" prefix="og: http://ogp.me/ns#"> <![endif]-->
<!--[if IE 7]><html class="no-js no-svg ie ie7 lt-ie9 lt-ie8" lang="en-US" prefix="og: http://ogp.me/ns#"> <![endif]-->
<!--[if IE 8]><html class="no-js no-svg ie ie8 lt-ie9" lang="en-US" prefix="og: http://ogp.me/ns#"> <![endif]-->
<!--[if gt IE 8]><!-->
<html class="no-js no-svg" lang="en-US" prefix="og: http://ogp.me/ns#">
	<!--<![endif]-->

	<head>
		<meta charset="UTF-8" />
		<meta name="description" content="">
		<title>Ipsen Corporate</title>
		<link rel="stylesheet" href="main.css" type="text/css" media="screen" />
		
	</head>

	<body class="page-template-default page page-id-388 page-parent cookies-not-set language-en-US" data-glow="0, 111, 238">

		<div class="block" id="ipsen-history">
			<div class="horizontal-timeline">
				<div class="horizontal-timeline__bg" style="background-image: url()"></div>
				<h2>Ipsen history</h2>
				<div class="timeline-slider">
					<div class="timeline-slider__carousel">
						<div class="slide">
							<div class="timeline-pod ">
								<div class="timeline-pod__title">
									<div class="title">2017</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>Early 2017: Acquisition of oncology assets from Merrimack pharmaceuticals</p>
									<br>
									<a href="#modal-timeline-1" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-1" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">2017</h4>
										<p><img class="size-full wp-image-678 aligncenter" src="" alt="" width="200" height="200" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07132042/2017.png 200w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07132042/2017-150x150.png 150w" sizes="(max-width: 200px) 100vw, 200px" /></p>
										<p>Paris (France), 9 January 2017 – Ipsen announced that it has entered into a definitive agreement to acquire global oncology assets from Merrimack Pharmaceuticals, including its key marketed product ONIVYDE® (irinotecan liposome injection) for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy, in combination with fluorouracil and leucovorin. Under the terms of the agreement, Ipsen will gain exclusive commercialization rights for the current and potential future ONIVYDE indications in the U.S., as well as the current licensing agreements with Shire for commercialization rights ex-U.S. and PharmaEngine for Taiwan. The transaction also includes Merrimack’s commercial and manufacturing infrastructure, and generic doxorubicin HCl liposome injection. The transaction represents a unique opportunity and a strong strategic fit for Ipsen. ONIVYDE is a clinically differentiated and FDA-approved product for patients with high unmet medical needs.2017</p>

									</div>
								</div>
							</div>
						</div>
						
						
						<div class="slide">
							<div class="timeline-pod  reverse ">
								<div class="timeline-pod__title">
									<div class="title">2014</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>Ipsen’s SOMATULINE® DEPOT® gets FDA approval</p>
									<br>
									<a href="#modal-timeline-4" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-4" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">2014</h4>
										<p><img class="size-medium wp-image-682 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07133058/Somatuline-300x171.jpg" alt="" width="300" height="171" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07133058/Somatuline-300x171.jpg 300w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07133058/Somatuline-768x438.jpg 768w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07133058/Somatuline-1024x584.jpg 1024w" sizes="(max-width: 300px) 100vw, 300px" /></p>
										<ul>
											<li>SOMATULINE<sup>®</sup> DEPOT<sup>®  </sup>(lanreotide) Injection 120 mg (referred to as SOMATULINE<sup>®</sup>) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Pancreatic and gastrointestinal neuroendocrine tumors are rare cancers. There are an estimated 112,000 individuals currently living with pancreatic and gastrointestinal neuroendocrine tumors in the U.S<b></b></li>
											<li>Ipsen announces FDA acceptance of filing for DYSPORT<sup>®</sup> in the treatment of upper limb spasticity in adult patients<b></b></li>
											<li>Ipsen and the Salk Institute renew their agreement for discovery research in medical sciences. The 2011-2014 collaboration enabled significant steps forward in the understanding of basic biological mechanisms. Ipsen to support innovative Salk investigations into biology for another three years</li>
											<li>The Fondation Ipsen celebrates its 30th anniversary with a prestigious conference on the perspectives of cancer research, “Biology viewed through the prism of cancer”, attended by 8 Nobel Prize laureates and the greatest scientists in biomedical research.</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod ">
								<div class="timeline-pod__title">
									<div class="title">2013</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>Teijin Pharma Limited and Ipsen launched SOMATULINE® in Japan</p>
									<br>
									<a href="#modal-timeline-5" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-5" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">2013</h4>
										<p><img class="size-medium wp-image-683 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07133541/Signes%C2%A9G%C3%A9rardUf%C3%A9ras_120033-1.jpg" alt="" width="200" height="300" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07133541/Signes%C2%A9G%C3%A9rardUf%C3%A9ras_120033-1.jpg 529w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07133541/Signes%C2%A9G%C3%A9rardUf%C3%A9ras_120033-1-200x300.jpg 200w" sizes="(max-width: 200px) 100vw, 200px" /></p>
										<ul>
											<li>Teijin Pharma Limited and Ipsen launch of SOMATULINE<sup>®</sup> 60/90/120 mg for subcutaneous injection in Japan for the treatment of acromegaly and pituitary gigantism.</li>
											<li>Ipsen and Inspirations Biopharmaceuticals announce closing of the sale of OBI-1 and Milford facility to Baxter International</li>
											<li>Health Canada has granted amarketing authorization for DYSPORT<sup>®</sup> for the temporary improvement in the appearance of moderate to severe glabellar lines in adult patients under 65 years of age. Medicis Aesthetics Canada, a division of Valeant Pharmaceuticals, will market DYSPORT<sup>®</sup> for use in aesthetic medicine in Canada.</li>
											<li>Christel Bories joins Ipsen as Deputy CEO. Working alongside Marc de Garidel, Chairman and CEO, Christel Bories is responsible for accelerating the execution of the Group’s strategy.</li>
											<li>Ipsen strengthens its neurology R&amp;D capabilities with the acquisition of Syntaxin, a leader in recombinant botulinum toxin technology.</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod  reverse ">
								<div class="timeline-pod__title">
									<div class="title">2012</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>Ipsen enters into a research partnership with Oncodesign to develop new therapeutic agents</p>
									<br>
									<a href="#modal-timeline-6" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-6" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">2012</h4>
										<p><img class="size-full wp-image-684 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07134052/2012-ActiveBiotech.jpg" alt="" width="200" height="150" /></p>
										<ul>
											<li>Ipsen and Active Biotech present encouraging results from the tasquinimod Phase II study in chemotherapy-naïve metastatic castrate resistant prostate cancer and initiate a new phase II, proof-of-concept clinical trial to evaluate the safety and efficacy of tasquinimod in other cancer indications.</li>
											<li>SOMATULINE<sup>®</sup> receives marketing authorization in Japan for the treatment of acromegaly and pituitary gigantism and becomes Ipsen’s first drug available worldwide.</li>
											<li>Inspiration Biopharmaceuticals, Inc., Ipsen’s partner, initiates a voluntary reorganization plan of its activities under the Chapter 11 of US Bankruptcy Code.</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod ">
								<div class="timeline-pod__title">
									<div class="title">2011</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>Ipsen announces a new development strategy based on three pillars</p>
									<br>
									<a href="#modal-timeline-7" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-7" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">2011</h4>
										<p><img class="size-medium wp-image-685 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07135257/rsz_12011_strat%C3%A9gie-1.jpg" alt="" width="200" height="300" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07135257/rsz_12011_strat%C3%A9gie-1.jpg 1872w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07135257/rsz_12011_strat%C3%A9gie-1-200x300.jpg 200w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07135257/rsz_12011_strat%C3%A9gie-1-768x1152.jpg 768w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07135257/rsz_12011_strat%C3%A9gie-1-683x1024.jpg 683w" sizes="(max-width: 200px) 100vw, 200px" /></p>
										<p>Ipsen announces a new comelopment strategy based on three pillars:</p>
										<ul>
											<li>Focus resources and investments on specialty care</li>
											<li>Invest to grow through the comelopment of new compounds and product life-cycle management programs</li>
											<li>Leverage the full potential of the Group’s geographical footprint</li>
										</ul>
										<p>Ipsen and the Salk Institute renew the “Ipsen Life Sciences Program” for a further three years.</p>
										<p>Syntaxin and Ipsen enter into a strategic agreement to comelop novel botulinum-toxin therapeutics.</p>
										<p>Ipsen strengthens its business in urology-oncology with the acquisition of the rights to HEAVY<sup>®</sup> (a drug aimed at improving bladder cancer detection) and the establishment of two significant partnerships with: Active Biotech for the co-comelopment and commercialization of tasquinimod (a molecule for the treatment of metastatic and castration-resistant prostate cancers), and Institut Gustave Roussy in the area of medical oncology to leverage the combined expertise of their respective R&amp;D teams.</p>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod  reverse ">
								<div class="timeline-pod__title">
									<div class="title">2010</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>Ipsen and Inspiration Biopharmaceuticals Inc. enter into a partnership</p>
									<br>
									<a href="#modal-timeline-8" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-8" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">2010</h4>
										<p><img class="size-full wp-image-686 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07140033/Rhythm-1.png" alt="" width="200" height="85" /></p>
										<ul>
											<li>Ipsen and Inspiration Biopharmaceuticals Inc. enter into a partnership to create a hemophilia franchise.</li>
											<li>Ipsen increases its presence in oncology and endocrinology in South-East Asia through a commercialization agreement with Invida.</li>
											<li>Ipsen grants Menarini exclusive license rights to ADENURIC<sup>®</sup> (for the treatment of chronic hyperuricemia in gout) in 41 countries. Ipsen retains co-promotion rights in France.</li>
											<li>Ipsen and Rhythm Pharmaceuticals, a biotechnology company comeloping peptide therapeutics for metabolic diseases, enter into a license agreement for Ipsen’s proprietary peptide therapeutics targeting obesity, metabolic diseases, and gastrointestinal disorders.</li>
											<li>Ipsen grants Rhythm an exclusive worldwide license for research, comelopment, and commercialization of its melanocortin and ghrelin programs originating from Ipsen’s research.</li>
											<li> Marc de Garidel is appointed Chairman and Chief Executive Officer</li>
										</ul>
										<p>&nbsp;</p>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod ">
								<div class="timeline-pod__title">
									<div class="title">2009</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>Ipsen and Galderma receive collective green light for AZZALURE® from 15 European countries</p>
									<br>
									<a href="#modal-timeline-9" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-9" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">2009</h4>
										<p><img class="size-medium wp-image-687 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07140343/rsz_2009_azzalure-200x300.jpg" alt="" width="200" height="300" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07140343/rsz_2009_azzalure-200x300.jpg 200w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07140343/rsz_2009_azzalure-768x1152.jpg 768w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07140343/rsz_2009_azzalure-683x1024.jpg 683w" sizes="(max-width: 200px) 100vw, 200px" /></p>
										<ul>
											<li>Ipsen and Galderma receive collective green light for AZZALURE<sup>®</sup> from 15 European countries’ Health Authorities for the granting of national marketing authorizations for the treatment of glabellar lines.</li>
											<li>AZZALURE<sup>®</sup> receives marketing authorization in the UK, France and Germany. The FDA approves DYSPORT™ for therapeutic and aesthetic use.</li>
											<li>The European Medicines Agency (EMA) delivers marketing authorization for the 6-month formulation of DECAPEPTYL<sup>®</sup> in nine European countries. The product is launched in France</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod  reverse ">
								<div class="timeline-pod__title">
									<div class="title">2008</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>Ipsen initiates a partnership with the Salk Institute for Biological Studies (San Diego)</p>
									<br>
									<a href="#modal-timeline-10" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-10" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">2008</h4>
										<p><img class="size-medium wp-image-713 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07145559/2008_SalkInstitute-300x200.jpg" alt="" width="300" height="200" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07145559/2008_SalkInstitute-300x200.jpg 300w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07145559/2008_SalkInstitute.jpg 430w" sizes="(max-width: 300px) 100vw, 300px" /></p>
										<ul>
											<li>Ipsen initiates a partnership with the Salk Institute for Biological Studies (San Diego, US) aimed at improving understanding of proliferative and degenerative diseases.</li>
											<li>Ipsen reinforces its presence in the US with three acquisitions: Tercica Inc. in endocrinology, APOKN<sup>®</sup> in neurology and Vernalis’ US commercial operations, and all assets related to OBI-1 from Octagen in hematology.</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod ">
								<div class="timeline-pod__title">
									<div class="title">2007</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>The Group enters into a partnership with Galderma</p>
									<br>
									<a href="#modal-timeline-11" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-11" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">2007</h4>
										<p><img class="size-full wp-image-714 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07145829/logo-ispen1.jpg" alt="" width="200" height="150" /></p>
										<ul>
											<li>The Group enters into a partnership with Galderma, for the comelopment, promotion and distribution of the Group’s botulinum toxin type A in aesthetic medicine indications.</li>
											<li>SOMATULINE<sup>®</sup> DEPOT obtains marketing authorization in the United States for the treatment of acromegaly. SOMATULINE<sup>®</sup> DEPOT is the first product stemming from Ipsen’s R&amp;D to be approved by the FDA.</li>
											<li>Ipsen’s shares are admitted to the SBF 120 index in France.</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod  reverse ">
								<div class="timeline-pod__title">
									<div class="title">2006</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>Ipsen enters into an agreement with Medicis (now Valeant)</p>
									<br>
									<a href="#modal-timeline-12" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-12" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">2006</h4>
										<p><img class="size-full wp-image-715 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07150136/2006-Tercica.jpg" alt="" width="200" height="150" /></p>
										<ul>
											<li>Ipsen enters into an agreement with Medicis (now Valeant) to market its botulinum toxin in aesthetic medicine indications in the US, Canada and Japan.</li>
											<li>Ipsen and Tercica complete worldwide strategic collaboration agreement in Endocrinology. Ipsen grants Tercica exclusive rights to market SOMATULINE<sup>®</sup> AUTOGEL<sup>®</sup> in the United States and in Canada.</li>
											<li>Tercica grants Ipsen exclusive rights to market INCRELEX™, a leading product in the United States for the treatment of short stature associated with severe primary IGF-1 deficiency in all territories excluding the United States, Japan, Canada, Taiwan and certain countries of the Middle East and North Africa.</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod ">
								<div class="timeline-pod__title">
									<div class="title">2005</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>Ipsen’s shares are listed on Euronext Paris.</p>
									<br>
									<a href="#modal-timeline-13" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-13" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">2005</h4>
										<p><img class="size-medium wp-image-716 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07150543/rsz_2005_ipsenenbourse-217x300.jpg" alt="" width="217" height="300" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07150543/rsz_2005_ipsenenbourse-217x300.jpg 217w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07150543/rsz_2005_ipsenenbourse-768x1064.jpg 768w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07150543/rsz_2005_ipsenenbourse-739x1024.jpg 739w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07150543/rsz_2005_ipsenenbourse.jpg 1318w" sizes="(max-width: 217px) 100vw, 217px" /></p>
										<ul>
											<li>Ipsen’s shares are listed on Euronext Paris.</li>
											<li>Ipsen enters into a licensing agreement with Radius through which Radius acquires the exclusive worldwide rights (excluding Japan) to develop, manufacture and distribute Ipsen’s osteoporosis proprietary molecule.</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod  reverse ">
								<div class="timeline-pod__title">
									<div class="title">2004</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>The Group opens a botulinum toxin manufacturing facility in Wrexham </p>
									<br>
									<a href="#modal-timeline-14" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-14" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">2004</h4>
										<p><img class="size-medium wp-image-717 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07150742/2004_Wrexham-300x157.jpg" alt="" width="300" height="157" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07150742/2004_Wrexham-300x157.jpg 300w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07150742/2004_Wrexham-768x402.jpg 768w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07150742/2004_Wrexham-1024x536.jpg 1024w" sizes="(max-width: 300px) 100vw, 300px" /></p>
										<ul>
											<li>The Group opens a botulinum toxin manufacturing facility in Wrexham (United Kingdom).</li>
										</ul>
										<p>&nbsp;</p>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod ">
								<div class="timeline-pod__title">
									<div class="title">2003</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>Ipsen and Teijin enter into an agreement to develop and market four Ipsen products</p>
									<br>
									<a href="#modal-timeline-15" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-15" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">2003</h4>
										<p><img class="size-full wp-image-718 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07150921/2003_Teijin1.jpg" alt="" width="200" height="75" /></p>
										<ul>
											<li>Ipsen and Teijin enter into an agreement to develop and market four Ipsen products, notably SOMATULINE<sup>®</sup> AUTOGEL<sup>®</sup>, in Japan and a Teijin product for the treatment of gout in Europe.</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod  reverse ">
								<div class="timeline-pod__title">
									<div class="title">2001-2002</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>Ipsen launches SOMATULINE® AUTOGEL® in the UK, France followed by many other countries.</p>
									<br>
									<a href="#modal-timeline-16" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-16" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">2001-2002</h4>
										<p><img class="size-medium wp-image-719 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07151255/2001-2002_SomatulineAutogel-300x208.jpg" alt="" width="300" height="208" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07151255/2001-2002_SomatulineAutogel-300x208.jpg 300w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07151255/2001-2002_SomatulineAutogel-768x532.jpg 768w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07151255/2001-2002_SomatulineAutogel-1024x710.jpg 1024w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07151255/2001-2002_SomatulineAutogel.jpg 1079w" sizes="(max-width: 300px) 100vw, 300px" /></p>
										<ul>
											<li>Ipsen launches SOMATULINE<sup>®</sup>AUTOGEL<sup>®</sup> in the UK, France followed by many other countries, strengthening Ipsen’s competitive position. To the Group’s knowledge, SOMATULINE<sup>®</sup> AUTOGEL<sup>®</sup> is the first semi-solid formulation for injection without any excipient, since the active substance controls the sustained release.</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod ">
								<div class="timeline-pod__title">
									<div class="title">2000</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>The Group is opening a manufacturing facility in China. </p>
									<br>
									<a href="#modal-timeline-17" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-17" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">2000</h4>
										<p><img class="size-medium wp-image-720 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07151507/2000_ChineSmecta-240x300.jpg" alt="" width="240" height="300" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07151507/2000_ChineSmecta-240x300.jpg 240w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07151507/2000_ChineSmecta-768x959.jpg 768w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07151507/2000_ChineSmecta-820x1024.jpg 820w" sizes="(max-width: 240px) 100vw, 240px" /></p>
										<p>&nbsp;</p>
										<ul>
											<li>The Group is opening a manufacturing facility in China. This facility will manufacture SMECTA® for the Chinese market, which is a reference treatment in the country.</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod  reverse ">
								<div class="timeline-pod__title">
									<div class="title">1996</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>Ipsen launches FORLAX®, a product used for the treatment of constipation.
									</p>
									<br>
									<a href="#modal-timeline-18" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-18" class="modal-hider timeline-pod__popup">
										<p style="text-align: center;">1996</p>
										<p><img class="size-medium wp-image-721 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07152153/1996_Forlax1-300x183.jpg" alt="" width="300" height="183" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07152153/1996_Forlax1-300x183.jpg 300w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07152153/1996_Forlax1-768x469.jpg 768w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07152153/1996_Forlax1-1024x626.jpg 1024w" sizes="(max-width: 300px) 100vw, 300px" /></p>
										<ul>
											<li>
												<div class="timeline-block picture left">
													<div class="timeline-content bounce-in">
														<div class="table">
															<div class="descrip item">Ipsen launches FORLAX<sup>®</sup>, a product used for the treatment of constipation.</div>
														</div>
													</div>
												</div>
												<div class="timeline-block picture right"></div>
											</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod ">
								<div class="timeline-pod__title">
									<div class="title">1995</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>The Group launches SOMATULINE®, a sustained-release peptide...</p>
									<br>
									<a href="#modal-timeline-19" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-19" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">1995</h4>
										<p><img class="size-medium wp-image-722 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07152348/1995_Somatuline1-300x183.jpg" alt="" width="300" height="183" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07152348/1995_Somatuline1-300x183.jpg 300w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07152348/1995_Somatuline1-768x470.jpg 768w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/07152348/1995_Somatuline1-1024x626.jpg 1024w" sizes="(max-width: 300px) 100vw, 300px" /></p>
										<ul>
											<li>The Group launches SOMATULINE<sup>®</sup>, its sustained-release peptide for the treatment of acromegaly and neuroendocrine tumors in France.</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod  reverse ">
								<div class="timeline-pod__title">
									<div class="title">1994</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>Ipsen acquires Speywood, the company that developed DYSPORT®</p>
									<br>
									<a href="#modal-timeline-20" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-20" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">1994</h4>
										<p><img class="size-medium wp-image-612 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06142047/1994_Dysport-195x300.jpg" alt="" width="195" height="300" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06142047/1994_Dysport-195x300.jpg 195w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06142047/1994_Dysport-768x1182.jpg 768w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06142047/1994_Dysport-665x1024.jpg 665w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06142047/1994_Dysport.jpg 1417w" sizes="(max-width: 195px) 100vw, 195px" /></p>
										<ul>
											<li>Ipsen acquires Speywood, the company that developed DYSPORT® for the treatment of movement disorders and various forms of muscular spasticity.</li>
											<li>This acquisition strengthens the Group’s presence in the UK and Northern Europe.</li>
											<li>Ipsen establishes a sales platform for its biological product and opens an office in Russia.</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod ">
								<div class="timeline-pod__title">
									<div class="title">1992</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>Ipsen begins its development in China, with the opening of a representative office...</p>
									<br>
									<a href="#modal-timeline-21" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-21" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">1992</h4>
										<p><img class="size-medium wp-image-611 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06141707/rsz_1992_chine-300x200.jpg" alt="" width="300" height="200" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06141707/rsz_1992_chine-300x200.jpg 300w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06141707/rsz_1992_chine-768x512.jpg 768w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06141707/rsz_1992_chine-1024x683.jpg 1024w" sizes="(max-width: 300px) 100vw, 300px" /></p>
										<ul>
											<li>Ipsen begins its development in China, with the opening of a representative office in Tianjin.</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod  reverse ">
								<div class="timeline-pod__title">
									<div class="title">1983</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>The Group creates La Fondation Ipsen under the aegis of the Fondation de France</p>
									<br>
									<a href="#modal-timeline-22" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-22" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">1983</h4>
										<p><img class="size-medium wp-image-610 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06141512/rsz_1983_fondation-214x300.jpg" alt="" width="214" height="300" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06141512/rsz_1983_fondation-214x300.jpg 214w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06141512/rsz_1983_fondation-768x1078.jpg 768w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06141512/rsz_1983_fondation-730x1024.jpg 730w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06141512/rsz_1983_fondation.jpg 1186w" sizes="(max-width: 214px) 100vw, 214px" /></p>
										<ul>
											<li>
												<div class="timeline-block picture left">
													<div class="timeline-content bounce-in">
														<div class="table">
															<div class="descrip item">The Group creates La Fondation Ipsen under the aegis of the Fondation de France. Its mission is to foster interactions between leading scientists in the field of life sciences.</div>
														</div>
													</div>
												</div>
												<div class="timeline-block picture right"></div>
											</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod ">
								<div class="timeline-pod__title">
									<div class="title">1980</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>Ipsen initiates a partnership with Debiopharm....</p>
									<br>
									<a href="#modal-timeline-23" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-23" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">1980</h4>
										<p><img class="size-medium wp-image-602 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06135400/1980-decapeptyl-200x300.jpg" alt="" width="200" height="300" /></p>
										<ul>
											<li>Ipsen initiates a partnership with Debiopharm. This collaboration leads to the marketing of DECAPEPTYL<sup>®</sup> in 1986. This analogue of natural GnRH hormone (or gonadotropin) is indicated for the treatment of prostate cancer, endometriosis and infertility. DECAPEPTYL<sup>®</sup> has been a key driver of the Group’s international expansion.</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod  reverse ">
								<div class="timeline-pod__title">
									<div class="title">1970</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>The Group enters an expansion phase...</p>
									<br>
									<a href="#modal-timeline-24" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-24" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">1970</h4>
										<p><img class="size-full wp-image-601 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06135140/1970-Ginkor.jpg" alt="" width="150" height="200" /></p>
										<ul>
											<li>The Group enters an expansion phase with the launch of GINKOR<sup>®</sup>, TANAKAN<sup>®</sup> and SMECTA<sup>®</sup>. The Group creates Laboratoires Ipsen (Institute of Synthetic Products from Natural Extraction).</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod ">
								<div class="timeline-pod__title">
									<div class="title">1969</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>The Group opens its first research facility in Les Ulis (France).</p>
									<br>
									<a href="#modal-timeline-25" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-25" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">1969</h4>
										<p><img class="size-medium wp-image-600 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06135053/1969_Les-Ulis-300x200.jpg" alt="" width="300" height="200" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06135053/1969_Les-Ulis-300x200.jpg 300w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06135053/1969_Les-Ulis-768x512.jpg 768w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06135053/1969_Les-Ulis-1024x683.jpg 1024w" sizes="(max-width: 300px) 100vw, 300px" /></p>
										<ul>
											<li>The Group opens its first research facility in Les Ulis (France).</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod  reverse ">
								<div class="timeline-pod__title">
									<div class="title">1954</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>The Group launches Citrate de BETAïNE®</p>
									<br>
									<a href="#modal-timeline-26" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-26" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">1954</h4>
										<p><img class="size-medium wp-image-599 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06135014/rsz_1954_citrate-de-betaine-215x300.jpg" alt="" width="215" height="300" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06135014/rsz_1954_citrate-de-betaine-215x300.jpg 215w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06135014/rsz_1954_citrate-de-betaine-768x1071.jpg 768w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06135014/rsz_1954_citrate-de-betaine-734x1024.jpg 734w" sizes="(max-width: 215px) 100vw, 215px" /></p>
										<ul>
											<li>The Group launches Citrate de BETAïNE®,a product used in the symptomatic treatment of dyspepsia.</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
						<div class="slide">
							<div class="timeline-pod ">
								<div class="timeline-pod__title">
									<div class="title">1929</div>
								</div>
								<div class="progress-bar"></div>
								<div class="active-dot"><span></span></div>
								<div class="timeline-pod__content">
									<p>Dr. Henri Beaufour creates Laboratoires Beaufour in Dreux (France) </p>
									<br>
									<a href="#modal-timeline-27" data-modal-open class="timeline-pod__read-more cta cta--link">
										<span class="cta__label">Read more
                                  <svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24">
                                    <path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"/>
                                  </svg>
                              </span>
									</a>

									<div id="modal-timeline-27" class="modal-hider timeline-pod__popup">
										<h4 style="text-align: center;">1929</h4>
										<p><img class="size-medium wp-image-598 aligncenter" src="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06134432/1929_Romarene-218x300.png" alt="" width="218" height="300" srcset="https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06134432/1929_Romarene-218x300.png 218w, https://d1bml1vmyeu9v2.cloudfront.net/websites/Ipsen_Online/wp-content/uploads/2018/11/06134432/1929_Romarene.png 611w" sizes="(max-width: 218px) 100vw, 218px" /></p>
										<ul>
											<li>Dr. Henri Beaufour creates Laboratoires Beaufour in Dreux (France) to launch ROMARÉNE<sup>®</sup>, a product derived from rosemary for the treatment of digestive disorders.</li>
										</ul>

									</div>
								</div>
							</div>
						</div>
					</div>
				</div>
			</div>
		</div>

		</div>
		<!-- <div class="achievements__vert-title"><div class="vertical-section-title">
  <div class="vertical-section-title--inner">
    <p></p>
  </div>
</div>
</div> -->
		</div>
		</div>
		</div>
		</main>

		<!-- Ipsen Corporate -->

		<div class="modal">
			<div class="modal-inner has-shadow">
				<button data-modal-close class="modal-close">
    	<svg id="nav-trigger" class="nav-trigger" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" width="32">
	  		<path id="cross" d="M5.65 7.443L7.064 6.03l10.48 10.48-1.415 1.414zM5.644 16.509l3.931-3.932 1.414 1.415-3.931 3.931zM12.194 9.956l3.931-3.932L17.54 7.44l-3.931 3.931z"/>
		</svg>
	</button>
				<div class="modal-content"></div>
			</div>
		</div>
		<div id="modal-leaving" class="modal-hider center external">
			<div class="external-modal-content">
				<p>You are now leaving the Ipsen Group section. If you would like to visit an affiliate section, please click Continue. The information provided on this section may not necessarily be applicable to the Ipsen Group.</p>

			</div>
			<div class="internal-modal-content">

			</div>
			<p style="text-align: center;">
				<a class="cta cta--primary cta--has-shadow no-modal-override" id="modal-leaving-continue" href="" style="margin: 0.5rem;"><span class="cta__label">Continue<svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"></path></svg></span></a>
				<a class="cta cta--secondary cta--has-shadow no-modal-override" id="modal-leaving-continue" href="#" onclick="closeLeavingModal()" style="margin: 0.5rem;"><span class="cta__label">Cancel<svg data-name="Calque 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M14.54 7.63l-1.5 1.13.67 2.21H5.18v2h8.53l-.67 2.2 1.5 1.13 5.32-3.5v-1.67l-5.32-3.5z"></path></svg></span></a>
			</p>
		</div>
		</div>

		<script src="https://code.jquery.com/jquery-3.1.0.js" integrity="sha256-slogkvB1K3VOkzAI8QITxV3VzpOnkeNVsKvtkYLMjfk=" crossorigin="anonymous"></script>

		<script src="https://cdnjs.cloudflare.com/ajax/libs/waypoints/4.0.1/noframework.waypoints.min.js"></script>

		<script src="https://d1bml1vmyeu9v2.cloudfront.net/wp-content/themes/ipsen-master/dist/bundlerrr.js"></script>

		<script src="https://d1bml1vmyeu9v2.cloudfront.net/wp-content/themes/ipsen-master/src/js/vendor/vanillamodal.js"></script>

</html>